Differential assay reactivity of immunglobulin A anti-ß<sub>2</sub> glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing.

Hood, David B; Snyder, Karin R; Buckner, Tammy R; Hurley, Beth L; Pitts, Kelly R; Lopez, Luis R

Differential assay reactivity of immunglobulin A anti-ß₂ glycoprotein I antibodies: implications for the clinical interpretation of antiphospholipid antibody testing.

Hood, David B; Snyder, Karin R; Buckner, Tammy R; Hurley, Beth L; Pitts, Kelly R; Lopez, Luis R.

Afiliação

Hood DB; Corgenix Medical Corporation, Broomfield, Colorado, USA.
Snyder KR; Corgenix Medical Corporation, Broomfield, Colorado, USA.
Buckner TR; Corgenix Medical Corporation, Broomfield, Colorado, USA.
Hurley BL; Corgenix Medical Corporation, Broomfield, Colorado, USA.
Pitts KR; Corgenix Medical Corporation, Broomfield, Colorado, USA.
Lopez LR; Corgenix Medical Corporation, Broomfield, Colorado, USA.

Eur J Rheumatol ; 2(4): 135-138, 2015 Dec.

Article em En | MEDLINE | ID: mdl-27708950

Palavras-chave

IgA anti-ß2 glycoprotein I; Systemic lupus erythematosus; antiphospholipid antibodies; antiphospholipid syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Ano de publicação: 2015 Tipo de documento: Article